Update on Febrile Neutropenia in Pediatric Oncological Patients Undergoing Chemotherapy
Open Access
Abstract
Febrile neutropenia (FN) is a common complication of chemotherapy in oncological children and one of the most important causes of morbidity and mortality in these patients. The early detection of a bacteremia and the rapid therapeutic intervention are crucial to improve the outcome. We analyzed the literature in order to clarify the epidemiology of FN in children undergoing chemotherapy, the specific factors associated with a negative outcome, the most common etiology, and the value of biological markers as a tool to make an early diagnosis or to monitor the evolution of the infection. Several studies have tried to identify specific factors that could help the clinician in the detection of an infection and in its microbiological identification. However, due to the heterogenicity of the available studies, sufficient evidence is lacking to establish the role of these risk factors in clinical practice and future research on this topic appear mandatory. Determinations of risk factors, etiology, and markers of febrile episodes in these patients are complicated by the characteristics of the underlying illness and the effects of treatments received. Although some studies have tried to develop an evidence-based guideline for the empiric management of FN in pediatrics, validated predictive scores and algorithms are still lacking and urgently needed.Keywords
This publication has 65 references indexed in Scilit:
- Increased interleukin-10 levels correlate with bacteremia and sepsis in febrile neutropenia pediatric oncology patientsCytokine, 2012
- Risk Factors Associated With Invasive Fungal Disease in Children With Cancer and Febrile NeutropeniaThe Pediatric Infectious Disease Journal, 2010
- INFECTIONS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA: An Analysis of 222 Febrile Neutropenic EpisodesPediatric Hematology and Oncology, 2008
- A prospective, multicentric scoring system to predict mortality in febrile neutropenic children with cancerCancer, 2007
- Pediatric cancer patients in clinical trials of sepsis: Factors that predispose to sepsis and stratify outcomePediatric Critical Care Medicine, 2005
- Predicting bacteremia in children with fever and chemotherapy-induced neutropeniaThe Pediatric Infectious Disease Journal, 2004
- Infectious complications in pediatric acute myeloid leukemia: analysis of the prospective multi-institutional clinical trial AML-BFM 93Leukemia, 2003
- Procalcitonin in paediatric cancer patients: its diagnostic relevance is superior to that of C-reactive protein, interleukin 6, interleukin 8, soluble interleukin 2 receptor and soluble tumour necrosis factor receptor IIBritish Journal of Haematology, 2000
- Bloodstream infections in children with cancer: a multicentre surveillance study of the Italian Association of Paediatric Haematology and OncologyEuropean Journal of Cancer, 1999
- Guidelines for the Use of Antimicrobial Agents in Neutropenic Patients with Unexplained Fever--ReplyThe Journal of Infectious Diseases, 1991